Evidence depth: moderate · High public-data fit

Ophthalmology

The highest-volume, most efficient outpatient surgical specialty. Income is driven by the sheer volume of cataracts, premium lens upgrades (cash-pay), and ASC ownership. The ultimate 'factory' specialty.

Build Your Report RVU calculator All specialties

Where to start

Best-fit Ophthalmology paths

Directional, modeled. Your priorities decide. Build a report to make it yours.

If you want the highest income

Retina (Vitreoretinal Surgery)

Extremely high.

$505k - $640k

See this path →

If you want the best lifestyle

Comprehensive / Cataract

High, volume-driven.

$420k - $535k

See this path →

If you want ownership upside

Comprehensive / Cataract

High, volume-driven.

$420k - $535k

See this path →

Data Highlights

Specialty Insights

Public data · NPPES24,753 clinicians in the NPI registry roster. Registration, not verified active practiceTop states: CA, NY, FLAggregate workforce/geography, not income.

Competitiveness context: very competitive - NRMP 2024

509 positions offeredhigh applicants-per-position tierSF Match 2024 ophthalmology residency statistics

Modeled Paths: 2
Top Modeled Ceiling: $900k - $1.8M+
Best Lifestyle Path: Comprehensive / Cataract
Highest Equity Upside: Comprehensive / Cataract

Public data · CMS Medicare Part B

What this specialty actually bills Medicare

Partial. Some procedure mix mapped

Aggregate allowed amount: $8.6B; Medicare Part B, not income
Providers in panel: 25,178; NPPES individual NPIs
NPI → Medicare join: 63%; billed Medicare in the year
Open Payments physicians: 15,004; transfers of value, not income

Medicare allowed-$ by subspecialty sector (public CMS data)

General Cataract

$995M

Retina

$22M

Top procedures by Medicare allowed-$ (public CMS data)

66984 · Removal of cataract with insertion of prosthetic lens$707M
92134 · Imaging of retina$247M
66821 · Removal of recurring cataract in lens capsule using a laser$171M
92083 · Exam of visual field with extended testing$106M
66982 · Complex removal of cataract with insertion of prosthetic lens$70M

Source: CMS Medicare Physician & Other Practitioners (public). This is not W-2 salary, total collections, or take-home income. Aggregate allowed amounts are a partial, biased slice of one payer; sector labels are keyword-inferred from public procedure descriptions and are directional, pending physician review.

Paths

Path families to test

Comprehensive / Cataract

High, volume-driven.

External benchmark reference: ~$400k

DoctorCalculator modeled estimate: Owner/Partner Ceiling: $700k - $1.5M+

View path →

Retina (Vitreoretinal Surgery)

Extremely high.

External benchmark reference: ~$550k

DoctorCalculator modeled estimate: Owner/Partner Ceiling: $900k - $1.8M+

View path →

Path Landscape

Compare all 2 paths

Premium tool

Unlock 10-dimension comparison matrix

See exactly how every path stacks up across lifestyle, sleep, ownership, and income.

Unlock premium

Path battle card

Compare head-to-head

Path A

Path B

Ophthalmology

Comprehensive / Cataract

Really about: high-efficiency cataract volume with premium cash-pay upgrades and ASC ownership

validated confidence

Ophthalmology

Retina (Vitreoretinal Surgery)

Really about: high-acuity ocular surgery and massive volume of macular degeneration injections

validated confidence

1. Income ceiling: Favorable
A very strong ceiling driven entirely by extreme surgical volume and cash-pay conversions.
The reality · The signal · The catch · The verdict
The reality: Cataract surgery takes 10-15 minutes; highly efficient surgeons can do 20-30 cases in a single day.
The signal: Premium intraocular lenses (IOLs) and laser-assisted cataract surgery are entirely cash-pay, bypassing Medicare cuts.
The catch: ASC ownership is absolutely mandatory to reach the upper decile of income.
The verdict: Provides an excellent, top-tier ceiling for a highly controllable, non-emergent lifestyle.; Favorable
One of the absolute highest ceilings in all of medicine.
The reality · The signal · The catch · The verdict
The reality: Driven by a massive volume of expensive intravitreal injections (Lucentis, Eylea) for macular degeneration.
The signal: The margin on drugs (the 'buy-and-bill' model) can generate staggering revenue.
The catch: Coupled with ASC ownership for vitrectomies, the financial leverage is immense.
The verdict: An incredible wealth-builder lane for the highly efficient operator.
2. Lifestyle controledge → Comprehensive / Cataract: Favorable
Exceptional control; widely considered a 'lifestyle' specialty.
The reality · The signal · The catch · The verdict
The reality: The practice is 100% outpatient, elective, and scheduled weeks in advance.
The signal: You have immense power to control the pace of your clinic and your surgical block time.
The catch: There are no hospital rounds, no messy bowel resections, and no unpredictable surgical delays.
The verdict: One of the absolute most controllable surgical specialties available in medicine.; Mixed
Significantly lower control than general ophthalmology.
The reality · The signal · The catch · The verdict
The reality: Retinal detachments are urgent, sight-threatening emergencies that do not respect the clock.
The signal: You will frequently be adding complex, 2-hour surgical cases to the end of an already exhausting day.
The catch: The clinic volume for injections is staggering (often 60+ patients a day).
The verdict: A highly profitable, but definitively grueling grind compared to cataracts.
3. Sleep / call burdenedge → Comprehensive / Cataract: Favorable
Extremely low burden; highly protective of your sleep.
The reality · The signal · The catch · The verdict
The reality: True ocular emergencies (like an open globe rupture) are usually triaged to major trauma centers or retinal specialists.
The signal: General ophthalmology call is mostly taking phone consults from the ER for pink eye or corneal abrasions.
The catch: If you are in a large private group, your call frequency is incredibly low.
The verdict: An ideal surgical path for those who demand protected sleep to function well.; Mixed
Moderate, driven by true ocular emergencies.
The reality · The signal · The catch · The verdict
The reality: Macula-on retinal detachments need to be fixed within 24 hours to save vision.
The signal: You are the end-of-the-line for severe ocular trauma and globe ruptures.
The catch: You will undoubtedly take some overnight and weekend call.
The verdict: Not an ideal path for those seeking perfectly protected sleep.
4. Ownership / facility upsideedge → Comprehensive / Cataract: Favorable
Massive upside driven by the 'golden triad' of ophthalmology.
The reality · The signal · The catch · The verdict
The reality: True wealth is built by owning the ASC, the Optical Shop (selling glasses and contacts), and mastering Premium IOL conversions.
The signal: You capture the professional surgical fee, the massive facility fee, and the retail margin on eyewear.
The catch: This highly optimized, diversified revenue stream is exactly why Private Equity is aggressively rolling up the specialty.
The verdict: The absolute ultimate owner-operator playbook in outpatient surgery.; Favorable
Very strong, but uniquely structured around pharmaceuticals.
The reality · The signal · The catch · The verdict
The reality: You still benefit from ASC ownership for your surgical cases.
The signal: However, the real 'ownership' wealth is the buy-and-bill margin on the incredibly expensive retinal drugs.
The catch: This is a very different business model than cataract surgery, heavily reliant on Medicare drug reimbursement (ASP+6%).
The verdict: A highly lucrative model, though politically vulnerable to drug pricing reforms.
5. Geography flexibilityedge → Comprehensive / Cataract: Favorable
Universal demand ensures you can practice absolutely anywhere.
The reality · The signal · The catch · The verdict
The reality: Everyone gets cataracts if they live long enough; the patient base is entirely inescapable.
The signal: It is exceptionally easy to find a job or open a practice in highly desirable metropolitan areas.
The catch: You are not reliant on massive hospital infrastructure, allowing you to thrive in community settings.
The verdict: Provides excellent geographic freedom and leverage in contract negotiations.; Favorable
Good, but entirely dependent on a robust referral base.
The reality · The signal · The catch · The verdict
The reality: You rely exclusively on general ophthalmologists and optometrists to send you patients.
The signal: Markets in top-tier metropolitan areas are often saturated with established groups.
The catch: You must go where the referral network is open or be willing to aggressively network.
The verdict: Provides less geographic freedom than a generalist who can see anyone off the street.
6. Innovation / industry adjacencyedge → Retina (Vitreoretinal Surgery): Mixed
Solid, heavily focused on optical physics and surgical efficiency.
The reality · The signal · The catch · The verdict
The reality: There is a constant, rapid evolution of premium intraocular lenses and femtosecond lasers.
The signal: Some surgeons build lucrative consulting relationships with major ophthalmic device companies (Alcon, J&J).
The catch: However, it is not a major driver of device royalties compared to orthopedics or cardiology.
The verdict: The primary focus remains on clinical efficiency and business scaling.; Favorable
High, heavily focused on biotechnology and pharmaceuticals.
The reality · The signal · The catch · The verdict
The reality: Gene therapy for inherited retinal diseases (like Luxturna) is exploding.
The signal: There is a constant, lucrative pipeline of new, longer-acting anti-VEGF drugs.
The catch: Offers very strong industry consulting potential with major pharma companies.
The verdict: An intellectually stimulating field at the absolute cutting edge of genetic medicine.
7. Training opportunity costedge → Comprehensive / Cataract: Favorable
One of the shortest and most efficient surgical training pathways.
The reality · The signal · The catch · The verdict
The reality: Requires a 1-year internship plus a 3-year residency (4 years total).
The signal: The ophthalmology match is notoriously competitive, requiring top-tier board scores.
The catch: Crucially, no fellowship is required to reach the absolute top income tiers doing cataracts.
The verdict: Features an unbeatable, highly rational financial ROI on your training years.; Mixed
Requires a 4-year residency plus a highly competitive 2-year fellowship.
The reality · The signal · The catch · The verdict
The reality: This amounts to 6 years of training before you reach attending status.
The signal: The surgical learning curve for vitrectomies is steep and demanding.
The catch: However, it is a completely reasonable and rational investment for the massive income jump.
The verdict: A highly lucrative ROI on the fellowship years.
8. Job-market densityedge → Comprehensive / Cataract: Favorable
Extremely strong demand driven by inescapable demographics.
The reality · The signal · The catch · The verdict
The reality: A massive, rapidly aging 'silver tsunami' population drives endless cataract demand.
The signal: Both employed and private partnership roles are incredibly plentiful nationwide.
The catch: The real challenge is finding an independent group with a fair, transparent partnership track.
The verdict: You will have ultimate job security in this field.; Mixed
Good, but structurally concentrated.
The reality · The signal · The catch · The verdict
The reality: A community only needs 1 retina specialist for every 4-5 general ophthalmologists.
The signal: This concentrates the jobs into larger groups and specific referral networks.
The catch: However, there is a massive shortage of retina surgeons relative to the aging diabetic population.
The verdict: Provides strong negotiating leverage once you find the right group.
9. Malpractice / litigation pressureedge → Comprehensive / Cataract: Mixed
Relatively low compared to high-acuity surgical specialties.
The reality · The signal · The catch · The verdict
The reality: Complications (endophthalmitis, dropped nucleus) certainly happen but are statistically rare.
The signal: The overall acuity of the patients is low, meaning devastating, life-threatening outcomes are practically non-existent.
The catch: Maintains a highly manageable medico-legal profile.
The verdict: Much lower baseline stress than specialties that deal constantly with death and severe morbidity.; Mixed
Moderate; higher stakes than general ophthalmology.
The reality · The signal · The catch · The verdict
The reality: You are dealing with patients who are actively losing their vision; the emotional stakes are high.
The signal: Endophthalmitis (severe infection) after a routine clinic injection is a constant, terrifying fear.
The catch: However, patients often understand the dire nature of their retinal disease.
The verdict: Manageable risks, but a significantly higher baseline stress than doing premium cataracts.
10. Burnout-mismatch riskedge → Comprehensive / Cataract: Favorable
Low risk, provided you do not mind repetitive, microscopic 'factory' work.
The reality · The signal · The catch · The verdict
The reality: If you hate high-volume clinic (seeing 40-60 patients a day) and rapid turnover, you will quickly burn out.
The signal: Requires a highly specific 'factory' mindset to efficiently process the volume without losing focus.
The catch: An absolutely excellent fit for wealth-builders and lifestyle-seekers who want microscopic surgical skills.
The verdict: Low mismatch risk if you understand the clinical reality of the specialty.; Mixed
Moderate risk if you hate the repetitive clinic grind.
The reality · The signal · The catch · The verdict
The reality: Requires a massive tolerance for high clinic volume and giving dozens of eye injections every single day.
The signal: If you want a slow, thoughtful clinic where you spend 30 minutes counseling patients, this is absolutely not it.
The catch: You must be highly efficient and comfortable with a 'production line' mentality.
The verdict: Only for the highly efficient operator who loves the pathology.
11. What people regret: • Assuming high volume would make you rich, only to realize the real wealth requires convincing patients to pay out-of-pocket for premium lenses.
• Selling the practice and the ASC to private equity too early and becoming a highly paid technician in your own shop.; • The crushing realization that you are effectively a pharmacist, giving 60 eye injections a day, rather than a pure surgeon.
• The physical and emotional toll of managing patients who are slowly, inevitably going blind.
12. Best-fit archetypes: Owner-Operator Physician, Lifestyle-First Clinician; Procedure-Heavy Wealth Builder, Owner-Operator Physician
13. Poor-fit archetypes: Prestige-Risk Academic, Acute-Care Identity Seeker; Lifestyle-First Clinician
14. Questions to ask mentors / fellowships / jobs: • What is the exact buy-in structure for the ASC, and how quickly can I start operating there?
• What percentage of the group's cataract volume successfully converts to premium (cash-pay) Toric or Multifocal lenses?
• Has the group been approached or bought by private equity, and are there onerous non-competes in this market?; • What is the actual call burden for retinal detachments, and do you share it with other competing groups?
• How is the massive revenue from intravitreal injections (anti-VEGF) distributed among the partners?
• Is the practice heavily reliant on a single referring general ophthalmology group?

Evidence & reveals

Clinician assumptionmoderate

Ophthalmology wealth relies heavily on ASC ownership and premium lens conversion.

Why · signal · limit · impact

Why: Without the facility fee, doing 20 cataracts a day is exhausting and underpaid.

Signal: Industry data shows cash-pay upgrades (refractive cataract surgery) are a massive profit center.

Caveat: Do not take a private job without a clear path to ASC ownership.

Impact: Push for ownership.

Curated field notemoderate

Retina income is heavily leveraged by the buy-and-bill model for anti-VEGF drugs.

Why · signal · limit · impact

Why: The markup on these expensive drugs drives practice revenue.

Signal: Medicare cuts to drug reimbursement (ASP+6%) directly impact the bottom line.

Caveat: The surgical volume is the fun part, but the injections pay the bills.

Impact:

Scores are relative, directional signals, not dollars and never a salary claim. Each carries its own why, supporting signal, limitation, and decision impact, and the confidence badge shows how validated each path is.

Field notes

Ophthalmology private equity roll-ups are currently among the most aggressive in healthcare, driven by the aging population's massive cataract demand and lucrative ASC revenue.

Common regret patterns

Getting trapped in an employed model where you do 30 cataracts a day but only get paid the Medicare professional fee ($600) while the hospital keeps the $2000 facility fee.
Underestimating the repetitive physical strain on the neck and back from the microscope.

Questions to ask

Where did recent graduates land, and at what real compensation model?
What's the realistic path to ownership or production upside?

Run your personalized report

Premium turns your target life into a required-income number, then tests it against these paths for salary-only gap, ownership upside, call burden, and geography. Evidence depth and confidence stay visible inside every report.

Build Your Report